000 | 03403cam a22004938i 4500 | ||
---|---|---|---|
001 | 23126574 | ||
005 | 20240227125228.0 | ||
008 | 230512s2024 dcu b 001 0 eng | ||
010 | _a 2023022897 | ||
020 |
_a9781615374892 _q(paperback ; _qalk. paper) |
||
020 |
_z9781615374908 _q(ebook) |
||
040 | _aDNLM/DLC | ||
042 | _apcc | ||
050 | 0 | 0 | _aRJ504.7 |
060 | 0 | 0 | _aWS 350.33 |
082 | 0 | 0 | _a615.7/80835 |
245 | 0 | 0 |
_aClinical manual of child and adolescent psychopharmacology / _cedited by Molly McVoy, Ekaterina Stepanova, Robert L. Findling. |
250 | _aFourth edition. | ||
263 | _a2308 | ||
264 | 1 |
_aWashington, DC : _bAmerican Psychiatric Association Publishing, _c[2024] |
|
300 | _apages cm | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_aunmediated _bn _2rdamedia |
||
338 |
_avolume _bnc _2rdacarrier |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aDevelopmental Aspects of Pediatric Psychopharmacology -- Attention-Deficit/Hyperactivity Disorder -- Disruptive Behavior Disorders and Aggression -- Anxiety Disorders -- Major Depressive Disorder -- Bipolar Disorders -- Autism Spectrum Disorder -- Tic Disorders -- Early-Onset Schizophrenia and Psychotic Illnesses -- Eating Disorders. | |
520 | _a"When it comes to the use of psychotropic agents in pediatric patients, it is not merely a question of extrapolating data from adults to children and adolescents; special consideration must be given to the effects of the drug on developing bodies and brains. That is what makes this fourth edition of the Clinical Manual of Child and Adolescent Psychopharmacology so essential. Updated to include a succinct yet thorough review of the most recent evidence-based information and data-driven best treatment practices in child and adolescent psychiatry, this new volume is organized by DSM-5-TR diagnosis and offers an exhaustive analysis of the use of drugs in nine disorder categories that include depressive disorders, attention-deficit/hyperactivity disorder, autism spectrum disorder, eating disorders, and early schizophrenia and psychotic illnesses. Each chapter includes comprehensive medication tables that allow easy reference of dosing, side effects, and tips for management as well as key points that summarize the most essential information for treating clinicians. Whether they are clinical psychiatrists, medical students on psychiatry rotation, advanced practice providers, or pediatricians, readers will benefit from the depth of information in this indispensable desktop reference"-- | ||
520 | _cProvided by publisher. | ||
650 | 1 | 2 |
_aMental Disorders _xdrug therapy |
650 | 1 | 2 | _aChild |
650 | 2 | 2 |
_aPsychopharmacology _xmethods |
650 | 2 | 2 |
_aPsychotropic Drugs _xtherapeutic use |
650 | 2 | 2 | _aAdolescent |
700 | 1 | _aMcVoy, Molly, | |
700 | 1 |
_aStepanova, Ekaterina _c(Psychiatrist), |
|
700 | 1 | _aFindling, Robert L, | |
710 | 2 |
_aAmerican Psychiatric Association Publishing, _eissuing body. |
|
776 | 0 | 8 |
_iOnline version: _tClinical manual of child and adolescent psychopharmacology _bFourth edition. _dWashington, DC : American Psychiatric Association Publishing, [2024] _z9781615374908 _w(DLC) 2023022898 |
906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
999 |
_c70431 _d70431 |